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Dual protective role for Glutathione S-transferase class pi against VCD-
induced ovotoxicity in the rat ovary
Abstract
The occupational chemical 4-vinylcyclohexene diepoxide (VCD) selectively destroys ovarian small pre-antral
follicles in rats and mice via apoptosis. Detoxification of VCD can occur through glutathione conjugation,
catalyzed by glutathione S-transferase (GST) enzymes. Further, GST class pi (GSTp) can negatively regulate
JNK activity through protein:protein interactions in extraovarian tissues. Dissociation of this protein complex
in the face of chemical exposure releases the inhibition of pro-apoptotic JNK. Increased JNK activity during
VCD-induced ovotoxicity has been shown in isolated ovarian small pre-antral follicles following in vivo
dosing of rats (80mg/ Kg/d; 15d, i.p). The present study investigated the pattern of ovarian GSTp expression
during VCD exposure. Additionally, the effect of VCD on an ovarian GSTp:JNK protein complex was
investigated. PND4 F344 rat ovaries were incubated in control medium ± VCD (30 μM) for 2-8d. VCD
increased ovarian GSTp mRNA (P <0.05) relative to control on d4-d8; whereas GSTp protein was increased
(P < 0.05) on d6-d8. A GSTp:JNK protein complex was detected by immunoprecipitation and Western
blotting in ovarian tissues. Relative to control, the amount of GSTp-bound JNK was increased (P = 0.09),
while unbound JNK was decreased (P < 0.05) on d6 of VCD exposure. The VCD-induced decrease in
unbound JNK was preceded by a decrease in phosphorylated c-Jun which occurred on d4. These findings are
in support of a possible dual protective role for GSTp in the rat ovary, consisting of metabolism of VCD and
inhibition of JNKinitiated apoptosis.
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Abstract
The occupational chemical 4-vinylcyclohexene diepoxide (VCD) selectively destroys ovarian
small pre-antral follicles in rats and mice via apoptosis. Detoxification of VCD can occur through
glutathione conjugation, catalyzed by glutathione S-transferase (GST) enzymes. Further, GST
class pi (GSTp) can negatively regulate JNK activity through protein:protein interactions in extra-
ovarian tissues. Dissociation of this protein complex in the face of chemical exposure releases the
inhibition of pro-apoptotic JNK. Increased JNK activity during VCD-induced ovotoxicity has
been shown in isolated ovarian small pre-antral follicles following in vivo dosing of rats (80mg/
Kg/d; 15d, i.p). The present study investigated the pattern of ovarian GSTp expression during
VCD exposure. Additionally, the effect of VCD on an ovarian GSTp:JNK protein complex was
investigated. PND4 F344 rat ovaries were incubated in control medium ± VCD (30 μM) for 2-8d.
VCD increased ovarian GSTp mRNA (P <0.05) relative to control on d4-d8; whereas GSTp
protein was increased (P < 0.05) on d6-d8. A GSTp:JNK protein complex was detected by
immunoprecipitation and Western blotting in ovarian tissues. Relative to control, the amount of
GSTp-bound JNK was increased (P = 0.09), while unbound JNK was decreased (P < 0.05) on d6
of VCD exposure. The VCD-induced decrease in unbound JNK was preceded by a decrease in
phosphorylated c-Jun which occurred on d4. These findings are in support of a possible dual
protective role for GSTp in the rat ovary, consisting of metabolism of VCD and inhibition of JNK-
initiated apoptosis.
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Introduction
4-vinylcyclohexene (VCH) is an occupational chemical formed by dimerization of 1,3-
butadiene and is produced as a by-product in the pesticide, rubber, plastic and flame
retardant industries (Rappaport and Fraser, 1977). A metabolite of VCH, 4-
vinylcyclohexene diepoxide (VCD) is used as an industrial diluent for epoxides (IARC,
1976). VCD is ovotoxic and specifically destroys small pre-antral follicles (primordial and
primary) in ovaries of rats and mice (Kao et al., 1999; Smith et al., 1990) by enhancing the
natural process of atresia in a time- and dose-dependent manner (apoptosis; Devine et al.,
2002a; Springer et al., 1996a,b,c; Hu et al., 2001a,b; 2002). In the ovary the cytochrome
P450 enzyme isoform CYP2E1 may play a role in converting VCH to the ovotoxic form,
VCD (Cannady et al., 2003; Rajapaska et al., 2007a). Ovarian detoxification of VCD to
inactive metabolites is catalyzed through the action of microsomal epoxide hydrolase (mEH)
and the glutathione S-transferase (GST) family of enzymes.
GST comprise a large family of enzymes that catalyze the conjugation of glutathione (GSH)
to a variety of xenobiotics, allowing for their inactivation and more rapid excretion. There
are a number of classes of GST enzymes, alpha, mu, omega, pi, sigma and theta, and each of
these in turn contains a number of isoforms. The mouse ovary has been shown to synthesize
GSH (Luderer et al., 2001), and form VCD-GSH adducts (Rajapaska et al., 2007b). A
previous study in cultured postnatal day (PND) 4 B6C3F1 mouse ovaries showed no effect of
VCD on mRNA encoding GST classes alpha, omega or theta (Keating et al., 2008).
However, VCD exposure increased (P < 0.05) mRNA encoding GST classes pi (GSTp) and
mu (GSTm) on d4 by 1.55- and 1.7-fold, respectively. Yet this effect was reversed on d6
and d8. GSTp, but not GSTm protein was elevated by 47% after 8d of VCD exposure. It was
hypothesized that in mice, despite early up-regulation of GST, repeated VCD exposure
eventually overwhelmed the induction of GST enzymes, thereby reducing its detoxification
capacity during the onset of ovotoxicity (Keating et al., 2008).
In addition to its role in glutathione conjugation, the GST family has another possible
indirect role in regulation of cell signaling. GSTp has been shown to form a protein complex
with JNK and c-Jun (Adler et al., 1999), keeping JNK in an inactive state. This interaction
prevents JNK mediated phosphorylation and activation of c-Jun (phosphorylated c-Jun; p-c-
Jun). Following chemical exposure, this complex dissociates, relieving the inhibitory action
of GSTp on JNK (Adler et al., 1999). A role for both JNK and p-c-Jun during VCD-induced
ovotoxicity has been demonstrated. Following 15d of daily dosing of rats with VCD (80mg/
Kg; i.p.), relative to controls, both JNK (protein and activity) and p-c-Jun (protein) increased
in isolated small pre-antral follicles (targeted by VCD; Hu et al., 2002).
An in vitro culture system has been developed using ovaries from PND4 rats (enriched in
small pre-antral follicles) to examine in vitro effects of ovotoxicants without a metabolic
influence from the liver (Devine et al., 2002b; 2004). Whether the GST and JNK pathways
interact in the ovary as in other tissues is unknown. Therefore, the present study was
designed to characterize in rats the association between VCD and GSTp mRNA and protein
as relates to VCD-induced follicle loss using the in vitro ovary culture system. The
formation of an ovarian GSTp and JNK-containing protein complex was also investigated.
Materials and Methods
Reagents
VCD (mixture of isomers, >99% purity), 2-β-mercaptoethanol, 30% acrylamide/0.8% bis-
acrylamide, ammonium persulfate, glycerol, N’,N’,N’,N’-Tetramethyl-ethylenediamine
(TEMED), Tris base, Tris HCl, sodium chloride, Tween-20, bovine serum albumin (BSA),
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ascorbic acid (Vitamin C), phosphatase inhibitor, protease inhibitor and transferrin were
purchased from Sigma-Aldrich Inc. (St Louis, MO). Dulbecco’s Modified Eagle Medium:
nutrient mixture F-12 (Ham) 1X (DMEM/Ham’s F12), albumax, penicillin/streptomycin
(5000U/ml, 5000 μg/ml, respectively), Hanks’ Balanced Salt Solution (without CaCl2,
MgCl2, or MgSO4), custom designed primers, and superscript III one-step RT-PCR System
were obtained from Invitrogen Co. (Carlsbad, CA). Millicell-CM filter inserts, anti-p-c-Jun
and anti-GSTp ant ibodies were purchased from Millipore (Bedford, MA). 48 well cell
culture plates were obtained from Corning Inc. (Corning, NY). RNeasy Mini kit,
QIAshredder kit, RNeasy MinElute kit, and Quantitect™ SYBR Green PCR kit were
purchased from Qiagen Inc. (Valencia, CA). Anti-JNK antibody was purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). Anti-ACTB antibody and agarose G beads were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Goat anti-rabbit and goat anti-
mouse secondary antibodies were purchased from Pierce Biotechnology (Rockford, IL).
Animals
A breeding colony was established from Fischer 344 (F344) rats that were originally
purchased from Harlan Laboratories (Indianapolis, IN) to use as a source of PND4 female
rat pup ovaries for culture. All pregnant animals were housed singly in plastic cages, and
maintained in a controlled environment (22 ± 2°C; 12h light/ 12h dark cycles). Animals
were provided a standard diet with ad libidum access to food and water, and allowed to give
birth. All animal experiments were approved by the University of Arizona’s Institutional
Animal Care and Use Committee.
In vitro ovarian culture
Ovaries from PND4 F344 rats were cultured as described by Devine et al. (2002a). Briefly,
PND4 female F344 rats were euthanized by CO2 inhalation followed by decapitation. Each
ovary was removed, the oviduct and excess tissue were trimmed, and it was placed on a
piece of Millicell-CM membrane floating on 250 μl of DMEM/Ham’s F12 medium
containing 1 mg/ml BSA, 1 mg/ml Albumax, 50 μg/ml ascorbic acid, 5 U/ml penicillin/5 μg/
ml streptomycin, and 27.5 μg/ml transferrin per well in a 48 well plate previously
equilibrated to 37°C. Using fine forceps, a drop of medium was placed to cover the top of
the ovary to prevent drying. Plates containing ovaries were cultured at 37°C and 5% CO2 in
air. Culture media was used as a solvent for VCD. The concentration of VCD used (30 μM)
was determined previously to cause loss of primordial and small primary follicles following
6 days of exposure using the in vitro rat ovary culture system (Keating et al., 2009). For
those cultures lasting more than 2d, media were removed and fresh media and treatment
were replaced every 2d.
RNA isolation
Following 2, 4, 6 or 8d of in vitro culture, ovaries treated with control or VCD (30 μM) were
stored in RNAlater at −80°C. Total RNA was isolated (n=3; 10 ovaries per pool) using an
RNeasy Mini kit. Briefly, ovaries were lysed and homogenized using a motor pestle
followed by applying the mixture onto a QIAshredder column. The QIAshredder column
containing ovarian tissue sample was then centrifuged at 14,000 rpm for 2 min. The
resulting flow-through was applied to an RNeasy mini column, allowing RNA to bind to the
filter cartridge. Following washing, RNA was eluted from the filter, and concentrated using
an RNeasy MinElute kit. Briefly, isolated RNA was applied to an RNeasy MinElute spin
column, and after washing, RNA was eluted using 14 μL of RNase-free water. RNA
concentration was determined using an ND-1000 Spectrophotometer (λ = 260/280nm;
NanoDrop technologies, Inc., Wilmington, DE).
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First strand cDNA synthesis and real-time polymerase chain reaction (PCR)
Total RNA (0.5 μg) was reverse transcribed into cDNA utilizing the Superscript III One-
Step RT-PCR System. cDNA was diluted (1:25) in RNase-free water. Two microliters of
diluted cDNA were amplified on a Rotor-Gene 3000 using Quantitect™ SYBR Green PCR
kit and custom designed primers as described in Keating et al. (2008). The cycling program
consisted of a 15 min hold at 95°C and 45 cycles of: denaturing at 95°C for 15s, annealing at
58°C for 15s, and extension at 72°C for 20s at which point data were acquired. Product melt
conditions were determined using a temperature gradient from 72°C to 99°C with a 1°C
increase at each step. There was no difference in β-actin (Actb) mRNA between control and
VCD treated ovaries. Therefore, each sample was normalized to ACTB before quantification
using the 2−ΔΔCt method.
Protein Isolation
Pools of whole ovarian protein (10-20 ovaries/pool) homogenates were prepared from
cultured ovaries via homogenization in tissue lysis buffer containing protease and
phosphatase inhibitors as previously described (Thompson et al., 2005). For
immunoprecipitation protein isolation, SDS was omitted from the tissue lysis buffer. Briefly,
homogenized samples were placed on ice for 30 min, followed by two rounds of
centrifugation at 10,000 rpm for 15 min. Supernatant was aliquoted and stored at −80°C
until further use. Protein was quantified using a standard BCA protocol on a 96-well assay
plate. Emission absorbance was detected with a λ= 540nm excitation on a Synergy™ HT
Multi-Detection Microplate Reader using KC4™ software (Bio-Tek® Instruments Inc.,
Winooski, VT). Protein concentrations were calculated from a BSA protein standard curve.
Protein Immunoprecipitation
Ovarian protein (100 μg) was incubated overnight at 4°C with 20 μl of anti-GSTp antibody.
Protein G agarose beads were washed, added to the protein-antibody mixture and incubated
at 4°C for 3 hours with turning. This mixture was centrifuged at 10,000rpm, and the
supernatant (unbound fraction) was removed for Western blotting. The beads were washed
three times with tissue lysis buffer (500 μl). Laemmli sample buffer (20 μl) was added and
beads incubated at 95°C for 10 mins. The beads were centrifuged and 10 μl supernatant
(bound fraction) was used for Western blotting.
Western Blot Analysis
SDS-PAGE (10%) was used to separate protein homogenates (n=3; 10 μg total protein or 10
μl unbound or bound immunoprecipitation fractions) and subsequently transferred onto
nitrocellulose membranes as previously described (Thompson et al., 2005). Briefly,
membranes were blocked for 1 h with shaking at 4°C in 5% milk in Tris-buffered saline
with Tween-20 (TTBS). Membranes were incubated with primary antibody in 5% milk in
TTBS overnight at 4°C. Antibody dilutions used were anti-GSTp (1:200), anti-p-c-Jun
(1:500), anti-JNK (1:500) and anti-ACTB (1:5000). Membranes were washed three times for
10 min each with TTBS. HRP-conjugated secondary antibody (1:2000 dilution) was added
for 1 h at room temperature. Membranes were washed three times for 10 min each in TTBS,
followed by a single wash for 10 min in Tris Buffered Saline (TBS). Western blots were
detected by chemiluminescence (using ECL plus chemiluminescence detection substrate)
and exposed to X-ray film. Densitometry of the appropriate bands was perfomed using
ImageJ software (NCBI). Individual treatment values were normalized to ACTB for total
protein and immunoprecipitated unbound protein and expressed as a percentage of the
control mean. Bound immunoprecipitated JNK was normalized to GSTp protein and
expressed as a percentage of the control mean.
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Statistical analysis
Comparisons were made between treatments using Statview software Fisher’s protected
least significant difference (PLSD) multiple range test. Statistical analysis was carried out on
raw data and, for graphical purposes, values were expressed as a percentage of control (n =
3), and one control value of 100% presented per graph. The assigned level of significance
for all tests was P < 0.05, with P < 0.1 considered as a trend for a difference.
Results
Temporal effect of VCD on GSTp mRNA in F344 rat ovaries—Previous studies
have determined that VCD-induced follicle loss in PND4 rat ovaries begins on d6 of culture
(Keating et al., 2009). In order to compare changes in GSTp mRNA expression over the
time-course of VCD-induced ovotoxicity, PND4 F344 rat ovaries were cultured in VCD (30
μM) for 2, 4, 6, or 8d. Relative to control ovaries, GSTp mRNA was increased (P < 0.05) on
d4-d8 (Figure 1 - d2: CT = 1, VCD = 0.92 ± 0.33; d4: CT = 1, VCD = 1.91 ± 0.19 - 91%
increase; d6: CT = 1, VCD = 2.19 ± 0.16 - 119% increase; d8: CT = 1, VCD = 1.74 ± 0.08 -
74% increase).
Temporal effect of VCD on GSTp protein in F344 rat ovaries—The effect of VCD
on GSTp protein level was evaluated by Western blotting. PND4 F344 rat ovaries were
cultured in control media or media containing VCD (30 μM) for 4, 6, or 8d. There was no
effect of VCD on GSTp protein on d4. Relative to control, GSTp protein levels were
increased (P < 0.05) on d6 and d8 (Figure 2 - d4: CT = 4.41 ± 0.33, VCD = 4.1 ± 0.12; d6:
CT = 3.55 ± 0.26, VCD = 5.49 ± 0.39 - 54% increase; d8: CT = 4.37 ± 0.18, VCD = 5.55 ±
0.19 - 27% increase).
Presence of and effect of VCD on GSTp:JNK protein complex formation in
F344 rat ovaries—In order to investigate the existence of ovarian protein complex
formation between GSTp, and JNK at a time prior to (d4) and at the time of (d6) VCD-
induced follicle loss, PND4 F344 rat ovaries were cultured for 4d and 6d in control media.
Immunoprecipitation was performed using an anti-GSTp antibody followed by Western
blotting to detect JNK. The presence of an ovarian GSTp:JNK protein complex was detected
on d4 and d6 of culture (Figure 3A). The presence of an ovarian GSTp:p-c-Jun protein
complex was also detected (data not shown).
The effect of VCD (30 μM) on the amount of JNK complexed with GSTp at a time prior to
(d4) and at the time of (d6) VCD-induced follicle loss was assessed in F344 PND4 rat
ovaries. There was no effect of VCD on d4, but there was a trend for an increase (P = 0.09)
in the ratio of JNK to GSTp in the protein complex on d6 (Figure 3B - d4: CT = 3.22 ± 0.29,
VCD = 3.33 ± 0.12; d6: CT = 2.46 ± 0.04, VCD = 2.85 ± 0.31 - 15.8% increase). The
amount of GSTp-bound JNK protein was calculated by normalization to the total GSTp
protein present at both timepoints (d4 and d6). Relative to control, there was no effect of
VCD on JNK protein levels after 4d. There was a 74% increase (P < 0.05) in JNK protein
due to VCD exposure on d6 (Figure 3C - d4: CT = 3.21 ± 0.17, VCD = 3.33 ± 0.07; d6: CT
= 2.46 ± 0.02, VCD = 4.38 ± 0.27 - 74% increase). In addition, there was no effect of VCD
on the amount of p-c-Jun protein bound to GSTp (data not shown).
Effect of VCD on unbound JNK and p-c-Jun protein levels—The effect of VCD
exposure on the amount of unbound JNK and its downstream phosphorylation target, c-Jun,
at a time prior to (d4) and at the time of (d6) VCD-induced follicle loss was assessed in
F344 PND4 rat ovaries cultured in control media or media containing VCD (30 μM).
Western blotting was performed on non-immunoprecipitated protein to detect unbound JNK
and p-c-Jun. ACTB protein was monitored to assess gel loading efficiency (Figure 4A). The
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amount of unbound JNK was not changed on d4 in response to VCD exposure, but
decreased (P < 0.05) on d6 (Figure 4B - d4: CT = 0.52 ± 0.05, VCD = 0.44 ± 0.03; d6: CT =
2.0 ± 0.05, VCD = 1.71 ± 0.05 – 15.2% decrease). There was a decrease (P < 0.05) in the
amount of unbound p-c-Jun (Figure 4C - d4: CT = 1.16 ± 0.008, VCD = 1.08 ± 0.023 –
6.5% decrease; d6: CT = 1.31 ± 0.03, VCD = 1.15 ± 0.02 – 11.7% decrease).
Discussion
The ovary has the potential to detoxify VCD by VCD-glutathione (GSH) conjugate
formation through the action of the GST family of enzymes. VCD-GSH conjugates can then
be further processed and excreted from the body. VCD (30 μM) exposure in PND4 rat
ovaries results in loss of primordial and small primary follicles after 6d in culture (Keating
et al., 2009). Thus, an in vitro rat whole ovarian culture system (Devine et al., 2002a,b;
2004) was used in the present study to investigate ovarian expression of GSTp mRNA and
protein in response to VCD in rats. An increase in GSTp mRNA was first detected after d4
of VCD exposure and was sustained on d6 and d8. In addition, VCD increased GSTp protein
levels on d6 and d8. Thus, the increase in GSTp mRNA preceded the increase in GSTp
protein.
In neonatal mouse ovaries maintained in culture with VCD, GSTp mRNA was increased
only on d4 but returned to control levels on d6 and d8 (Keating et al., 2008). However, the
mouse studies used 15 μM VCD whereas 30 μM VCD was used in incubations of rat ovaries
in the present study. Thus, whether there are species differences between rats and mice
cannot be concluded from these findings. At any rate, these results collectively support a
role for GSTp in the response of ovaries to VCD in rats as well as mice.
In extra-ovarian tissues, GSTp has been shown to play a role in inhibiting the action of pro-
apoptotic JNK (Adler et al., 1999; Yu et al., 2009). GSTp forms a protein complex with
both JNK and c-Jun, preventing phosphorylation of c-Jun by JNK, thus acting as a negative
regulator of JNK-induced apoptosis (Adler et al., 1999). It is proposed that this protein
complex can become disrupted following an environmental stress exposure. This disruption
results in the release of GSTp for it to catalyze GSH conjugation to xenobiotics
(metabolism). As a result, there is relief of the inhibitory effect afforded by the protein
complex on JNK activity (Adler et al., 1999). This event then favors apoptosis. The
involvement of JNK and its downstream substrate, c-Jun, in VCD-induc ed ovotoxicity has
been shown following in vivo dosing of rats with VCD (80mg/Kg/day; i.p; Hu et al., 2002).
At the time of impending follicle loss, there was an increase in JNK activity and protein
(d10 and d15) and an increase in phosphorylated c-Jun (d15; protein; p-c-Jun - active state)
in small pre-antral (primordial and small primary) follicles isolated from dosed animals,
with no effect in the VCD non-target follicle pool (secondary follicles). Thus, a role for both
JNK and p-c-Jun was supported during VCD-induced ovotoxicity, however, an involvement
of GSTp protein was not evaluated in that study.
In the present study, GSTp and JNK were identified in an ovarian protein complex in
ovarian tissue suggesting a possible link between GSTp and the previously reported
involvement of both JNK and p-c-Jun in VCD-induced follicle loss (Hu et al., 2002). The
amount of GSTp protein as well as JNK protein bound to GSTp was increased in response to
VCD (d6). This increase in GSTp-bound JNK at the onset of follicle loss in cultured ovaries
corresponds to the increase in total JNK protein and activity in ovarian small follicles
isolated from VCD-dosed rats (Hu et al., 2002). In the present study, there was also a
concomitant decrease in the amount of unbound JNK protein on d6, indicating that the level
of free JNK that is available for initiating apoptosis has become limited. The VCD-induced
reduction in unbound JNK (d6) was preceded by a decrease in unbound p-c-Jun after 4d of
VCD exposure. Thus, although the decrease in unbound JNK was not seen until d6 of
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exposure, it is likely that JNK activity was affected prior to this time. This observation
supports that, in response to VCD, JNK pro-apoptotic activity (phosphorylation of c-Jun)
has become reduced prior to the onset of follicle loss (d6).
Ovotoxicity induced by VCD requires repeated daily dosing in vivo, or continuous exposure
in vitro. Interestingly, a single dose of VCD in rats was associated with decreased JNK
protein and activity in the follicles targeted by VCD (Hu et al., 2002). Furthermore, the
single dose of VCD protected against follicle loss 15d later (Borman et al., 1999).
Therefore, results of the present study show that the requirement for continuous exposure to
VCD may partially relate to an early induction of ovarian GSTp. Because JNK was found to
be complexed with GSTp, it is possible that the increase in GSTp serves to inhibit JNK
activity. Thus, initially, increased levels of GSTp may be sufficient to play a dual role in
protecting the ovary from VCD-induced ovotoxicity: (1) metabolism of VCD, and (2)
negative regulation of JNK activity.
In summary, the increase in expression of mRNA encoding GSTp in cultured neonatal rat
ovaries is maintained over the time-course of VCD-induced follicle loss. The increase in
GSTp protein induced by VCD is highest at the time that follicle loss is first seen (d6). The
interaction of GSTp with JNK corresponds to inhibition of JNK activity, as demonstrated by
the reduction in its downstream target, p-c-Jun. Taken together, these findings are in support
of a protective role for GSTp in the ovary, by catalyzing VCD-GSH adduct formation and
by inhibiting the action of JNK. Ultimately, however, it is possible that the repeated
chemical assault may compromise the capacity of GSTp to carry out both roles and
ovotoxicity commences. These findings raise concerns about low-dose repeated exposure of
women to ovotoxic chemicals which may pose a risk equal to or greater than a single
exposure to a higher dose (Borman et al., 2000).
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Figure 1. Temporal effect of VCD on GSTp mRNA
Ovaries from PND4 F344 rats were cultured with control (CT) medium or medium
containing 30 μM VCD for 2-8d. Following incubation, total RNA was isolated, reverse
transcribed to cDNA and analyzed for GSTp or Actb mRNA expression by RT-PCR. Values
are percentage of control ± SE; n=3 (8-10 ovaries per pool). *P < 0.05; different from
control.
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Figure 2. Temporal effect of VCD on GSTp protein
Ovaries from PND4 F344 rats were cultured with control (CT) medium or medium
containing 30 μM VCD for 4-8d. Following incubation, total protein was isolated and
Western blotting carried out for GSTp and ACTB. (A) Values are normalized to ACTB
protein and expressed as a percentage of control mean ± S.E.; n=3; * P <0.05; Different
from control. (B) Representative Western blot is shown on d6; control = c; VCD = v.
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Figure 3. Effect of VCD on GSTp:JNK protein complex formation
Ovaries from PND4 F344 rats were cultured with control (CT) medium or medium
containing 30 μM VCD for 4d (D4) or 6d (D6). Following incubation, total protein was
isolated and immunoprecipitation carried out using an anti-GSTp antibody as described in
materials and methods. (A) Representative Western blot of GSTp immunoprecipitation,
followed by detection of JNK protein (control ovary; d6). (B) Ratio of JNK protein bound to
GSTp on D4 and D6. (C) JNK protein relative to total GSTp. Values are percentage of
control ± SE. * P <0.05; # P < 0.1; Different from control.
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Figure 4. Effect of VCD on unbound JNK and p-c-Jun protein levels
Ovaries from PND4 F344 rats were cultured with control (CT) medium or medium
containing 30 μM VCD for 4d (D4) or 6d (D6). Following incubation, total protein was
isolated and immunoprecipitation carried out using an anti-GSTp antibody as described in
materials and methods. JNK or p-c-Jun proteins were detected by Western blotting. Image J
software was used to measure integrated density of protein bands. (A) Representative
Western blot for JNK, p-c-Jun and ACTB on d6; control = c; VCD = v. (B) Unbound JNK
protein level, normalized to ACTB. (C) Unbound p-c-Jun protein level, normalized to
ACTB. Values are expressed as percentage of control ± SE; n=3; *P <0.05; different from
control.
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